dna strand image

Announcements

GenePeeks Announces Additional Partnerships with The Donor Solution and 3 Sisters Surrogacy

CAMBRIDGE, MA Feb 28th, 2017

GenePeeks today announced partnerships with two leading fertility organizations: The Donor Solution, an independent egg donation agency, and 3 Sisters Surrogacy, a gestational carrier service. Through these partnerships, more prospective parents will have access to GenePeeks' proprietary preconception genetic screening test.

GenePeeks Appoints Industry Leader Matt Posard as President and Chief Commercial Officer

CAMBRIDGE, MA Feb 1st, 2017

Matt Posard joins the GenePeeks team with more than 25 years of experience successfully commercializing innovative technologies in the life science and molecular diagnostics fields. Over the course of his career, Posard has held influential leadership roles at a number of market leading companies including Illumina, Trovagene and Alere.

GenePeeks Launches Preconception Test for Combined Risk of Passing on More than 1,000 Serious Genetic Diseases

CAMBRIDGE, MA Jan 24th, 2017

GenePeeks today announced the launch of its proprietary next-generation screening platform. Powered by Virtual Progeny Analytics (VPA), the patented technology enables high-resolution visibility into the risk of conceiving a child with one or more of 1,000+ heritable diseases.

GenePeeks Study Compares Utility of Donor Carrier Screening Methods with Systematic Next Generation Sequence Analysis

NEW YORK, NY May 1st, 2016

The study spotlights the need to overhaul screening protocols to take advantage of the tremendous advances in human genomics that have occurred over the past decade.

GenePeeks and RMA of New York Launch Research Collaboration to Study Breakthrough Genetic Disease Screening Technology

NEW YORK, NY March 1st, 2016

GenePeeks and Reproductive Medicine Associates of New York (RMA of New York) announce their collaboration and the start of patient recruitment for a study evaluating the clinical performance of GenePeeks’ pre-conception risk prediction technology in comparison to expanded carrier screening.

Letter to the Editor of Genetics in Medicine: Response to Sosnay et al

NEW YORK, NY October 29, 2015

In this letter to the editor, we highlight an inherent limitation in the carrier screening framework for cystic fibrosis. We argue that computational tools are highly relevant to the development of a more effective response to disease risk identification and management.

Response to BuzzFeed Article: This Company Is Trying To Make More Perfect Babies

NEW YORK, NY July 13, 2015

It’s wonderful to have an ongoing conversation around genetics and health. We are not in pursuit of the "perfect baby," however that would ever be defined. We want what all parents want — a world where every child has the chance at a healthy future.

Seattle Infertility Center Introduces New Technology to Patients to Minimize Risk of Hundreds of Genetic Diseases in Their Children

SEATTLE, WA (PR Web) July 06, 2015

Pacific NW Fertility first in the United States to offer innovative genetic testing prior to making embryos utilizing donor eggs. Diseases hidden in the combined DNA of sperm and eggs can be revealed before fertilization takes place in the IVF process.

GenePeeks Appoints Mara G. Aspinall as Chairman of Board of Directors

NEW YORK & CAMBRIDGE, MA (Business Wire) March 19, 2015

Lifeprint Group, the parent company for GenePeeks, Inc., a genetic information company focused on next-generation disease risk analysis, announced today that Mara Aspinall has joined the company’s board of Directors as Executive Chairman. Aspinall brings deep experience building and leading successful life science companies to support the company’s continued growth.

GenePeeks Launches Sperm Donor Matching Service

(Bio IT World) May 22, 2014

GenePeeks has opened its in silico nursery, formally lunching the Matchright screening service for families who are planning to use a sperm donor to conceive. GenePeeks was awarded patents in late January for algorithms that simulate potential offspring.

GenePeeks Announces Issuance of US Patent for Pre-Conception Prediction of Disease Risk in Hypothetical Future Children

NEW YORK & CAMBRIDGE, MA (Business Wire) Jan 27, 2014

GenePeeks, Inc., a genetic technology company focused on pre-conception risk prediction, announced today it has been issued patent No. 8,620,594, titled “Method and System for Generating a Virtual Progeny Genome,” by the United States Patent and Trademark Office. The patent covers innovative algorithms that simulate the genetic interactions occurring naturally in human reproduction in order to create hypothetical “digital babies.”

For more information and media resources, please contact the GenePeeks team at press@genepeeks.com